PACAP 38 as a modulator of immune and endocrine responses during LPS-induced acute inflammation in rats
- 31 August 2006
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 177 (1-2), 76-84
- https://doi.org/10.1016/j.jneuroim.2006.04.013
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cellsThe FASEB Journal, 2004
- Pituitary Adenylate-Cyclase-Activating Polypeptide Expression in the Immune SystemNeuroimmunomodulation, 2002
- The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon SuperfamilyEndocrine Reviews, 2000
- VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cellsJournal of Neuroimmunology, 1999
- Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-JunPublished by Elsevier BV ,1998
- VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studiesJournal of Neuroimmunology, 1998
- Local Effect of PACAP and VIP on Testicular Function in Immature and Adult RatsPeptides, 1997
- Pituitary adenylate cyclase-activating polypeptides ( PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMPJournal of Neuroimmunology, 1995
- Effects of feeding lipids of different fatty acid compositions upon rat lymphocyte proliferationLife Sciences, 1994
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989